A comparison of fulvestrant and the third-generation aromatase inhibitors in the second-line treatment of postmenopausal women with advanced breast cancer (Q36134514)
scientific article
Language:
Current Data About A comparison of fulvestrant and the third-generation aromatase inhibitors in the second-line treatment of postmenopausal women with advanced breast cancer
(P31) (Q13442814)
(P248)
(P698) 15908126
(P813) Saturday, August 12, 2017

(P50) (Q89808263)
(P1545) 2
(P1932) Ignace Vergote
(P248)
(P698) 15908126
(P813) Saturday, August 12, 2017

(P304) 274-282
(P248)
(P698) 15908126
(P813) Saturday, August 12, 2017

(P407) (Q1860)

(P433) 4
(P248)
(P698) 15908126
(P813) Saturday, August 12, 2017

(P478) 31
(P248)
(P698) 15908126
(P813) Saturday, August 12, 2017

(P577) Wednesday, June 1, 2005
(P248)
(P698) 15908126
(P813) Saturday, August 12, 2017

(P921) (Q3040305)
(P887)

(P1433) (Q1955762)
(P248)
(P698) 15908126
(P813) Saturday, August 12, 2017

(P1476) "A comparison of fulvestrant and the third-generation aromatase inhibitors in the second-line treatment of postmenopausal women with advanced breast cancer" (language: en)
(P248)
(P698) 15908126
(P813) Saturday, August 12, 2017

(P2093) David Dodwell
(P1545) 1
(P248)
(P698) 15908126
(P813) Saturday, August 12, 2017

(P13046) (Q7318358)
(P248)

other details
description scientific article

External Links
(P356) 10.1016/J.CTRV.2005.03.009
(P698) 15908126